NDC 0074-3289

Tarka

Trandolapril And Verapamil Hydrochloride

Tarka is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Trandolapril; Verapamil Hydrochloride.

Product ID0074-3289_24e0ea84-0e19-eb4e-4583-3d3520d1ec5a
NDC0074-3289
Product TypeHuman Prescription Drug
Proprietary NameTarka
Generic NameTrandolapril And Verapamil Hydrochloride
Dosage FormTablet, Film Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date1996-10-22
Marketing End Date2021-09-13
Marketing CategoryNDA / NDA
Application NumberNDA020591
Labeler NameAbbVie Inc.
Substance NameTRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
Active Ingredient Strength2 mg/1; mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 0074-3289-13

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0074-3289-13)
Marketing Start Date1996-10-22
Marketing End Date2021-09-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-3289-28 [00074328928]

Tarka TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA020591
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-04-15
Marketing End Date2012-05-24

NDC 0074-3289-13 [00074328913]

Tarka TABLET, FILM COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA020591
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-10-22
Marketing End Date2021-09-13

Drug Details

Active Ingredients

IngredientStrength
TRANDOLAPRIL2 mg/1

OpenFDA Data

SPL SET ID:7023927e-1829-49c0-5c81-693489000d1c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 897855
  • 897785
  • 897844
  • 897781
  • 897783
  • 897782
  • 897846
  • 897853
    • UPC Code
  • 0300743290134
  • 0300743289138
  • 0300743287134

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Calcium Channel Antagonists [MoA]
    • Calcium Channel Blocker [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]

    NDC Crossover Matching brand name "Tarka" or generic name "Trandolapril And Verapamil Hydrochloride"

    NDCBrand NameGeneric Name
    0074-3287TarkaTrandolapril and Verapamil Hydrochloride
    0074-3289TarkaTrandolapril and Verapamil Hydrochloride
    0074-3290TarkaTrandolapril and Verapamil Hydrochloride
    59762-0122Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0132Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    59762-0142Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-294Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-295Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-296Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride
    68462-329Trandolapril and Verapamil HydrochlorideTrandolapril and Verapamil Hydrochloride

    Trademark Results [Tarka]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TARKA
    TARKA
    88897261 not registered Live/Pending
    Saule, LLC
    2020-05-01
    TARKA
    TARKA
    74604544 1994548 Live/Registered
    ABBVIE DEUTSCHLAND GMBH & CO. KG
    1994-11-30
    TARKA
    TARKA
    74418584 1874886 Dead/Cancelled
    Knoll AG
    1993-07-30
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.